Technology
Health
Biotechnology
INmune Bio
$5.359876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.57 (-9.62%) Today
+$0.03 (0.50%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell INmune Bio and other stocks, options, ETFs, and crypto commission-free!
About INMB
INmune Bio Inc. Common stock, also called INmune Bio, is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Read More Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
Employees
3
Headquarters
La Jolla, California
Founded
2015
Market Cap
57.29M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
59.58K
High Today
$5.72
Low Today
$5.06
Open Price
$5.72
Volume
23.34K
52 Week High
$11.50
52 Week Low
$5.06
Collections
Technology
Health
Biotechnology
Medical
Cancer Prevention
2019 IPO
US
North America
Price Paid on Robinhood
42% Lower
Right Now
52 Week Low
$7.00
Average Price Paid
$9.18
52 Week High
$11.00
INMB Earnings
-$0.20
-$0.20
-$0.19
-$0.19
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 20, Pre-Market